Addiction and Behavior Related to Menthol Cigarette Substitutes
NCT ID: NCT04844762
Last Updated: 2024-02-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2019-12-16
2021-08-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cooling Agent Pilot Among Adult Menthol Smokers
NCT06477601
Effective Ads for Quitting Smoking
NCT06485479
Smoking Topography and Harm Exposure in Menthol Cigarettes
NCT01329263
Evaluating the Impact of Synthetic Cooling Agents in Combustible Cigarettes on Smoking Perceptions and Use
NCT06230159
Manipulating Tobacco Constituents in Male Menthol Smokers
NCT02592772
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
usual brand menthol cigarette (UBMC)
Study participant's usual brand menthol cigarette
Menthol cigarettes substitutes
In Phase 1, participants will complete 4 smoking sessions using a different product each session to examine each product's abuse liability.
Menthol cigarettes substitutes and menthol cigarettes
In Phase 3, participants will complete a final in-lab visit to assess the substitutability of their preferred product from Phases 1 and 2, under simulated ban conditions using a progressive ratio task.
menthol roll-your-own cigarette (mRYO)
Mentholated pipe tobacco in a roll-your-own cigarette tube
Menthol cigarettes substitutes
In Phase 1, participants will complete 4 smoking sessions using a different product each session to examine each product's abuse liability.
Usual brand menthol cigarettes and substitutes
In Phase 2, to assess uptake, changes in subjective effects, and use over time, participants will select their preferred study product from Phase 1 and be instructed to completely substitute the product for their usual brand menthol cigarette for one week.
Menthol cigarettes substitutes and menthol cigarettes
In Phase 3, participants will complete a final in-lab visit to assess the substitutability of their preferred product from Phases 1 and 2, under simulated ban conditions using a progressive ratio task.
menthol filtered little cigar (mFLC)
The menthol filtered cigar will be Cheyenne (Cheyennecigars.com) Seneca (senecacigars.com)
Menthol cigarettes substitutes
In Phase 1, participants will complete 4 smoking sessions using a different product each session to examine each product's abuse liability.
Usual brand menthol cigarettes and substitutes
In Phase 2, to assess uptake, changes in subjective effects, and use over time, participants will select their preferred study product from Phase 1 and be instructed to completely substitute the product for their usual brand menthol cigarette for one week.
Menthol cigarettes substitutes and menthol cigarettes
In Phase 3, participants will complete a final in-lab visit to assess the substitutability of their preferred product from Phases 1 and 2, under simulated ban conditions using a progressive ratio task.
non-menthol cigarette (nmC)
The non-menthol cigarette will be Newport non-menthol cigarettes.
Menthol cigarettes substitutes
In Phase 1, participants will complete 4 smoking sessions using a different product each session to examine each product's abuse liability.
Usual brand menthol cigarettes and substitutes
In Phase 2, to assess uptake, changes in subjective effects, and use over time, participants will select their preferred study product from Phase 1 and be instructed to completely substitute the product for their usual brand menthol cigarette for one week.
Menthol cigarettes substitutes and menthol cigarettes
In Phase 3, participants will complete a final in-lab visit to assess the substitutability of their preferred product from Phases 1 and 2, under simulated ban conditions using a progressive ratio task.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Menthol cigarettes substitutes
In Phase 1, participants will complete 4 smoking sessions using a different product each session to examine each product's abuse liability.
Usual brand menthol cigarettes and substitutes
In Phase 2, to assess uptake, changes in subjective effects, and use over time, participants will select their preferred study product from Phase 1 and be instructed to completely substitute the product for their usual brand menthol cigarette for one week.
Menthol cigarettes substitutes and menthol cigarettes
In Phase 3, participants will complete a final in-lab visit to assess the substitutability of their preferred product from Phases 1 and 2, under simulated ban conditions using a progressive ratio task.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* between 18-24 (young adult) or 25-50 years old (aged 25+)
* willing to provide informed consent and abstain from all tobacco and nicotine use for at least 12 hours prior to the five lab sessions
* willing to complete one week of EMA
* read and speak English.
Exclusion Criteria
* unstable or significant psychiatric conditions (past and stable conditions will be allowed)
* history of cardiac event or distress within the past 3 months
* currently pregnant, planning to become pregnant, or breastfeeding (will be verified with urine pregnancy test)
* use of other tobacco products (e.g., e-cig, cigar, etc.) \>5 days in the past month
* current marijuana use \>5 times per month
* any use of other illicit drugs during the last 30 days (verified by urinalysis at initial visit)
* currently engaging in a smoking cessation attempt
* currently using one of the alternative menthol study products
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Vermont
OTHER
Brown University
OTHER
National Institutes of Health (NIH)
NIH
National Institute on Drug Abuse (NIDA)
NIH
Ohio State University Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Theodore Wagener
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Theodore Wagener, PhD
Role: PRINCIPAL_INVESTIGATOR
Ohio State University Comprehensive Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Villanti AC, Hinton A, Schulz JA, Erath TG, Mehta T, Reed D, Tidey J, Businelle M, Wagener TL. Substitutability of menthol cigarette alternatives: a clinical trial. Tob Control. 2025 Apr 1;34(2):154-161. doi: 10.1136/tc-2023-058272.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Jamesline
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OSU-19145
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.